central Venous Access Catheters
Clinicians like you asked Arrow to meet your needs. When you required a total, proven infection risk reduction solution, Arrow delivered. You asked for a wider array of catheter lengths, flow rates and customizable kits---and we gave you the broadest range of catheters in the industry. The bottom line: Arrow never stops working to engineer products that earn the trust of you and your patients.
Arrow offers one of the industry's most comprehensive ranges of CVCs and related products: from ARROWg+ard® catheters and uncoated catheters to scores of unique comprehensive kits that include an array of options, such as large barrier drape, ChloraPrep® and safety needles.
Arrow pioneered the antimicrobial-impregnated cathteter (our ARROWg+ard technology) in 1990. No other company's catheter has such a strong track record and broad spectrum of activity. In fact, over 30 studies and reviews prove ARROWg+ard catheter technology's ability to decrease the incidence of catheter-related bloodstream infection (CRBSI), reduce cost and save lives.1
ARROWg+ard reduces bacterial colonization of the catheter by 60 percent and catheter-related bacteremia by an even greater 80 percent.2 And it has been proven effective against a wide array of gram-positive bacteria, including S. epidermidis, MRSA and S. aureus; gram-negative bacteria, including Enterorocci and Pseudomonas strains; and fungi, including C. albicans.3
Now our latest breakthrough, ARROWg+ard Blue PLUS®, gives you that proven infection-fighting ability both outside and in, including extension lines and hubs. With ARROWg+ard Blue PLUS chlorahexidine and silver sulfadiazine continuously prep the subcutaneous catheter tract and kill organisms in places that you simply can't reach.
For more information, contact Arrow Customer Service.
1Veenstra, D.L., Saint, S., Saha, S., Lumley, T., Sullivan, S.D. "Cost-Effectiveness of Antiseptic-Impregnated Central Venous Catheters for the Prevention of Catheter-Related Bloodstream Infection," Journal of the American Medical Association, January 20, 1999, Vol. 281, Issue 3, pp. 261-267.
2Maki, D.G., Stolz, S.M., Wheeler, S., Mermel, L.A. “Prevention of Central Venous Catheter-Related Bloodstream Infection With an Antiseptic-Impregnated Catheter: A Randomized, Controlled Trial,” Annals of Internal Medicine, August 15, 1997, Vol. 127, Issue 4, pp. 257–266.
3References include but are not limited to Maki 1997, Sampath 1995 and Bach 1994.
ChloraPrep® is a registered trademark of Medi-Flex, Inc.